Evidence map›Paper›PMID 38645098›Full record

ArticlebioRxiv : the preprint server for biology2024

A framework for quality control in quantitative proteomics.

Kristine A Tsantilas, Gennifer E Merrihew, Julia E Robbins, Richard S Johnson, Jea Park, Deanna L Plubell, Jesse D Canterbury, Eric Huang, Michael Riffle, Vagisha Sharma and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Kristine A TsantilasDepartment of Genome Sciences, University of Washington, Washington 98195, United States.ORCID 0000-0002-4274-6930
Gennifer E MerrihewDepartment of Genome Sciences, University of Washington, Washington 98195, United States.ORCID 0000-0003-4903-0318
Julia E RobbinsDepartment of Genome Sciences, University of Washington, Washington 98195, United States.
Richard S JohnsonDepartment of Genome Sciences, University of Washington, Washington 98195, United States.
Jea ParkDepartment of Genome Sciences, University of Washington, Washington 98195, United States.
Deanna L PlubellDepartment of Genome Sciences, University of Washington, Washington 98195, United States.ORCID 0000-0002-6580-8073
Jesse D CanterburyThermo Fisher Scientific, 355 River Oaks Parkway, San Jose, California 95134, United States.
Eric HuangDepartment of Genome Sciences, University of Washington, Washington 98195, United States.
Michael RiffleDepartment of Biochemistry, University of Washington, Washington 98195, United States.ORCID 0000-0003-1633-8607
Vagisha SharmaDepartment of Genome Sciences, University of Washington, Washington 98195, United States.ORCID 0000-0003-1922-439X
Brendan X MacLeanDepartment of Genome Sciences, University of Washington, Washington 98195, United States.ORCID 0000-0002-9575-0255
Josh EckelsLabKey, 500 Union St #1000, Seattle, Washington 98101, United States.
Christine C WuDepartment of Genome Sciences, University of Washington, Washington 98195, United States.
Michael S BeremanDepartment of Biological Sciences, North Carolina State University, Raleigh, North Carolina 27607.ORCID 0000-0002-2722-064X
Sandra E SpencerCanada's Michael Smith Genome Sciences Centre (BC Cancer Research Institute), University of British Columbia, Vancouver, British Columbia V5Z 4S6, Canada.ORCID 0000-0001-6446-1584
Andrew N HoofnagleDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington 98195, United States.ORCID 0000-0002-6449-0243
Michael J MacCossDepartment of Genome Sciences, University of Washington, Washington 98195, United States.ORCID 0000-0003-1853-0256

Funding

University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Maitreya J Dunham · 1995 to 2026
$27.1M
Project 4: Novel reagent development to enable molecular characterizationU19AG065156 · NIA · UNIVERSITY OF WASHINGTON · PI TIAN, LU · 2020 to 2024
$15.9M
Seattle Quant: A Resource for the Skyline Software EcosystemR24GM141156 · NIGMS · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 2021 to 2026
$6.7M
Biological Mechanisms of Healthy Aging Training GrantT32AG066574 · NIA · UNIVERSITY OF WASHINGTON · PI David J. Marcinek, Jessica E Young · 2020 to 2026
$5.3M
Molecular Phenotyping in Alzheimer's DiseaseRF1AG053959 · NIA · STANFORD UNIVERSITY · PI LARSON, ERIC B, MACCOSS, MICHAEL · 2016 to 2017
$4.1M
Proteolytic activity profiling of Alzheimer's dementiaF31AG069420 · NIA · UNIVERSITY OF WASHINGTON · PI PLUBELL, DEANNA LISA · 2020 to 2021
$81k
NIA NIH HHS F31 AG069420NIA NIH HHS P30 AG013280NIA NIH HHS RF1 AG053959NIA NIH HHS T32 AG066574NIA NIH HHS U19 AG065156NIGMS NIH HHS R24 GM141156
6 · The paper itself

Abstract

A thorough evaluation of the quality, reproducibility, and variability of bottom-up proteomics data is necessary at every stage of a workflow from planning to analysis. We share vignettes applying adaptable quality control (QC) measures to assess sample preparation, system function, and quantitative analysis. System suitability samples are repeatedly measured longitudinally with targeted methods, and we share examples where they are used on three instrument platforms to identify severe system failures and track function over months to years. Internal QCs incorporated at protein and peptide-level allow our team to assess sample preparation issues and to differentiate system failures from sample-specific issues. External QC samples prepared alongside our experimental samples are used to verify the consistency and quantitative potential of our results during batch correction and normalization before assessing biological phenotypes. We combine these controls with rapid analysis (Skyline), longitudinal QC metrics (AutoQC), and server-based data deposition (PanoramaWeb). We propose that this integrated approach to QC is a useful starting point for groups to facilitate rapid quality control assessment to ensure that valuable instrument time is used to collect the best quality data possible. Data are available on Panorama Public and on ProteomeXchange under the identifier PXD051318.

Indexed as

DDADIAliquid chromatographymass spectrometryPRMproteomicsquality controlquantitative resultssample preparationsystem suitability

Identifiers

PMID38645098
PMCPMC11030400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.